• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Nuclear Medicine Market Size

    ID: MRFR/HC/5211-CR
    200 Pages
    Rahul Gotadki
    July 2025

    Nuclear Medicine Market Research Report By Application (Diagnostic Imaging, Therapeutic Applications, Radiopharmaceutical Production, Research Applications), By Radioisotope Type (Technetium-99m, Iodine-131, Fluorine-18, Yttrium-90), By End User (Hospitals, Diagnostic Imaging Centers, Academic Research Institutions, Pharmaceutical Companies), By Procedure (Positron Emission Tomography, Single-P...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Nuclear Medicine Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Nuclear Medicine Size

    Nuclear Medicine Market Growth Projections and Opportunities

    Nuclear Medicine Market size is expected to cross USD 24.03 billion by 2032, expanding at a CAGR of 13.2% during the forecast period. Numerous factors that jointly influence the Nuclear Medicine market make it highly dynamic. The field of nuclear medicine is unique and evolving within healthcare as it uses radioactive substances for diagnostic and therapeutic purposes. There are many chronic diseases, such as cancer and cardiovascular conditions, that impact the market significantly, with growing prevalence requiring prompt nuclear medicine techniques for precise diagnosis along with treatment options. Essential role players in the pharmaceutical industry, as well as the healthcare sector, influence this current market. The Nuclear Medicine market is largely driven by research into innovative radiopharmaceuticals and imaging technologies from both the pharmaceutical and healthcare sectors. New radionuclides and imaging techniques developed through technological advancements can greatly affect these markets, making them competitive among firms that want to offer more efficient methods for diagnosing different medical conditions. Regulatory factors play a crucial role in shaping the nuclear medicine market environment given its use of radioactive substances; hence, strict regulations and approval processes ensure the safety and efficacy of nuclear medicine procedures and products. The dynamics of the Nuclear Medicine market are also influenced substantially by economic considerations. Chronic diseases come at an economic burden and have serious implications for health diagnostics, thereby affecting adoption rates based on various demographics. Due to adverse economic conditions, patterns in healthcare spending, or lack of insurance coverage, individuals may find it difficult to access and afford recommended nuclear medicine procedures. The economic situation also controls investments made in new technology development within this area. Patient awareness programs have a huge impact on Nuclear Medicine initiatives. These efforts are aimed at increasing demand for these advanced diagnostic procedures, which will lead to more uptake levels through educating people about the advantages combined with the risks involved. Technological advancements in imaging modalities, as well as radiopharmaceutical development, also shape what happens in this industry. Positron emission tomography (PET), single-photon emission computed tomography (SPECT), and the development of targeted radiopharmaceuticals have all contributed to more personalized and accurate diagnostics and therapies. This not only improves the accuracy and effectiveness of nuclear medicine techniques but also creates prospects for theranostics, an approach that combines diagnosis with therapy using radioactive substances.

    Nuclear Medicine Market Size Graph

    Market Summary

    As per Market Research Future analysis, the Nuclear Medicine Market was valued at 10.63 USD Billion in 2024 and is projected to grow to 34.69 USD Billion by 2035, reflecting a CAGR of 11.35% from 2025 to 2035. The market is driven by the increasing prevalence of chronic diseases, advancements in diagnostic imaging technologies, and a rising geriatric population. Key regions contributing to growth include North America, Europe, and the Asia-Pacific, with significant investments in healthcare infrastructure and nuclear medicine applications.

    Key Market Trends & Highlights

    The Nuclear Medicine Market is witnessing transformative trends driven by technological advancements and demographic shifts.

    • Market Size in 2024: 10.63 USD Billion; expected to reach 34.69 USD Billion by 2035. Diagnostic Imaging segment valued at 2.1 USD Billion in 2024; projected to grow to 3.3 USD Billion by 2035. Technetium-99m remains a leading radioisotope, crucial for diagnostic imaging. North America holds the largest market share in 2024, valued at 2.73 USD Billion.

    Market Size & Forecast

    2024 Market Size USD 10.63 Billion
    2035 Market Size USD 34.69 Billion
    CAGR (2025-2035) 11.35%
    Largest Regional Market Share in 2024 North America.

    Major Players

    <p>MediRadiant, Bracco Imaging, Nordion, TheraBiologics, United Imaging Healthcare, Philips, Canon Medical Systems, SelenoMed, Radiopharm Theranostics, AquaBounty Technologies, Lantheus Medical Imaging, Bayer, Elekta, Siemens, General Electric.</p>

    Market Trends

    The Nuclear Medicine Market is experiencing significant growth driven by several key market drivers, particularly the rising incidence of cancer and cardiovascular diseases, which increase the demand for advanced diagnostic imaging and targeted therapies. The aging population globally is another critical factor, as older individuals are more susceptible to conditions warranting nuclear medicine interventions. 

    Advances in radiopharmaceutical technology are enhancing the accuracy and effectiveness of diagnostics and therapeutics, offering better patient outcomes and boosting market growth. In terms of opportunities, there is a growing potential in the development of personalized medicine, where nuclear medicine can play a vital role in tailoring treatments based on the individual characteristics of patients.Furthermore, investments in research and development are generating opportunities for the development of innovative products, such as novel radiotracers and therapies that more effectively target specific diseases.

    The significance of nuclear medicine in enhancing healthcare outcomes is being acknowledged by governments and health organizations worldwide, resulting in a rise in funding and support for initiatives in this field. 

    PET-CT technology and theranostics, which integrates therapy and diagnostics in a single approach, are recent trends in the Nuclear Medicine Market. This trend signifies a transition to more comprehensive treatment strategies, which improves the capacity to effectively monitor and treat diseases. Additionally, the prevalence of collaborations between technology companies and medical institutions is increasing, with the objective of optimizing production and distribution processes. This has the potential to resolve supply chain challenges and enhance access to nuclear medicine services.

    In general, the market is on the brink of significant growth, as its future trajectory is influenced by significant advancements in technology, healthcare delivery, and patient-centric approaches.

     

    <p>The Global Nuclear Medicine Market is poised for growth, driven by advancements in radiopharmaceuticals and increasing applications in diagnostics and therapeutics, which collectively enhance patient care and treatment outcomes.</p>

    U.S. Department of Energy

    Nuclear Medicine Market Market Drivers

    Market Growth Projections

    Increasing Demand for Diagnostic Imaging

    The Global Nuclear Medicine Market Industry experiences a notable surge in demand for diagnostic imaging techniques, particularly in oncology, cardiology, and neurology. As healthcare providers increasingly adopt advanced imaging modalities, the market is projected to reach 6.21 USD Billion in 2024. This growth is driven by the rising prevalence of chronic diseases and the need for early diagnosis. Nuclear medicine offers unique advantages, such as the ability to visualize physiological processes in real-time, which enhances treatment planning and patient outcomes. Consequently, the integration of nuclear imaging into routine clinical practice is likely to bolster the industry's expansion.

    Regulatory Support and Reimbursement Policies

    Regulatory support and favorable reimbursement policies are pivotal in shaping the Global Nuclear Medicine Market Industry. Governments and health authorities are increasingly recognizing the importance of nuclear medicine in improving patient outcomes, leading to the establishment of supportive regulatory frameworks. Additionally, reimbursement policies that cover nuclear medicine procedures encourage healthcare providers to adopt these technologies. This supportive environment is likely to stimulate market growth, as it enhances the financial viability of nuclear medicine services. Consequently, the industry is poised for expansion as more healthcare facilities integrate nuclear medicine into their offerings.

    Rising Awareness of Nuclear Medicine Benefits

    Rising awareness of the benefits of nuclear medicine among healthcare professionals and patients plays a crucial role in the Global Nuclear Medicine Market Industry. Educational campaigns and professional training programs are increasingly highlighting the advantages of nuclear imaging and therapy, such as their non-invasive nature and ability to provide functional information about diseases. This heightened awareness is likely to lead to increased utilization of nuclear medicine procedures, thereby driving market growth. As more healthcare providers recognize the value of these techniques, the industry is expected to expand significantly, aligning with the overall trends in personalized medicine.

    Growing Investments in Healthcare Infrastructure

    The Global Nuclear Medicine Market Industry benefits from growing investments in healthcare infrastructure, particularly in developing regions. Governments and private entities are increasingly allocating resources to enhance medical facilities and expand access to advanced diagnostic and therapeutic services. This trend is evident in countries such as India and Brazil, where initiatives to improve healthcare delivery systems are underway. As a result, the demand for nuclear medicine services is likely to rise, contributing to the market's projected growth to 10 USD Billion by 2035. Enhanced infrastructure facilitates the adoption of nuclear medicine technologies, ultimately improving patient care.

    Technological Advancements in Radiopharmaceuticals

    Technological advancements in radiopharmaceuticals significantly influence the Global Nuclear Medicine Market Industry. Innovations in drug development and imaging technologies enhance the efficacy and safety of nuclear medicine applications. For instance, the introduction of targeted radiotherapy agents has improved treatment outcomes for cancer patients. Moreover, advancements in imaging techniques, such as PET and SPECT, allow for more accurate disease detection and monitoring. As a result, the market is expected to grow at a compound annual growth rate of 4.43% from 2025 to 2035, reflecting the increasing reliance on these technologies in clinical settings.

    Market Segment Insights

    Nuclear Medicine Market Application Insights

    <p>The Nuclear Medicine Market is experiencing significant growth, particularly within the Application segment. Within this segment, Diagnostic Imaging stands out with a valuation of 2.84 USD Billion in 2024, rising to 4.5 USD Billion by 2035, indicating its major role in providing critical imaging technologies that enhance patient diagnosis and treatment planning. This area is pivotal as it enables physicians to visualize the internal functions of organs and tissues in real-time, leading to timely and accurate medical interventions.&nbsp;</p>

    <p>Following this, Therapeutic Applications are valued at 1.8 USD Billion in 2024 and expected to grow to 2.8 USD Billion by 2035. This segment plays a crucial role in treating diseases, such as cancer, using targeted radiotherapy that can minimize damage to surrounding healthy tissues, thus proving to be effective and beneficial for patient outcomes.</p>

    <p>Additionally, Radiopharmaceutical Production is a vital component of the market, with a valuation of 1.2 USD Billion in 2024, expected to increase to 1.9 USD Billion by 2035. It is essential as it supports the development and supply of radioactive substances for diagnostic and therapeutic purposes, ensuring that medical facilities have access to the necessary materials to perform various nuclear medicine procedures.&nbsp;</p>

    Nuclear Medicine Market Radioisotope Type Insights

    <p>The Nuclear Medicine Market is projected to reach a valuation of 6.21 USD Billion by 2024, driven by various factors, including advancements in diagnostic techniques and increasing prevalence of chronic diseases. Among the Radioisotope Type segment, Technetium-99m stands out for its extensive use in diagnostic imaging, making it a key player in the market.&nbsp;</p>

    <p>Iodine-131 is notably significant for its role in treating thyroid disorders, which further emphasizes its importance within the Nuclear Medicine Market. Fluorine-18, mainly utilized in positron emission tomography (PET) scans, continues to gain traction due to the growing demand for cancer diagnostics.Meanwhile, Yttrium-90 is recognized for its application in targeted beta therapy, enhancing treatment efficacy. The interplay of these radioisotopes underlines a strong market segmentation that reflects both diverse applications and growing trends in the Nuclear Medicine Market.</p>

    <p>The rising geriatric population and expansion in research and development efforts significantly contribute to this market growth, as does the increasing awareness and accessibility of nuclear medicine technologies across the globe.</p>

    Nuclear Medicine Market End User Insights

    <p>The Nuclear Medicine Market, valued at 6.21 USD Billion in 2024, is witnessing diverse dynamics across its End User segment, which encompasses Hospitals, Diagnostic Imaging Centers, Academic Research Institutions, and Pharmaceutical Companies. Hospitals stand out as a crucial component, driving significant demand for nuclear medicine procedures primarily focused on diagnostics and therapeutic applications. Diagnostic Imaging Centers are also vital, facilitating advancements in imaging technologies that enhance the accuracy of disease diagnosis.Academic Research Institutions play a key role in the exploration and development of new radioisotopes and imaging techniques, greatly contributing to the overall market growth.</p>

    <p>Furthermore, Pharmaceutical Companies are essential as they develop radiopharmaceuticals and invest in Research and Development to innovate treatment solutions.</p>

    <p>With a compound annual growth rate projected at 4.43 from 2025 to 2035, the Nuclear Medicine Market segmentation indicates a robust evolution in this field driven by technological advancements, increasing patient populations, and a rise in chronic diseases globally.Market challenges include regulatory hurdles and the high cost of radioisotope production; however, opportunities for growth persist as demand for personalized medicine rises and advancements in nuclear technologies continue.</p>

    Nuclear Medicine Market Procedure Insights

    <p>The Nuclear Medicine Market, focusing on the Procedure segment, is projected to be valued at 6.21 USD Billion in 2024, reflecting a strong demand for advanced diagnostic and therapeutic procedures. This segment encompasses various techniques, including Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT), which play a crucial role in the early detection of diseases, particularly cancer.&nbsp;</p>

    <p>PET, known for its high sensitivity, is becoming increasingly important in oncological imaging, while SPECT continues to be widely used due to its cost-effectiveness and accessibility.Additionally, Radiotherapy and Brachytherapy contribute significantly to the treatment landscape, offering targeted cancer therapies that enhance patient outcomes. The growth in this market is driven by an increasing prevalence of cancer, advancements in imaging technology, and growing investments in Research and Development. However, challenges such as high costs and regulatory hurdles may impact market expansion.&nbsp;</p>

    <p>Nevertheless, the ongoing innovations and integrative approaches within these procedures present substantial opportunities for growth in the Nuclear Medicine Market, contributing to its significant evolution over the next decade.</p>

    Get more detailed insights about Nuclear Medicine Market Research Report- Forecast till 2035

    Regional Insights

    The Nuclear Medicine Market is experiencing substantial growth across various regions, reflecting the increasing adoption of nuclear medicine in diagnostics and treatment. In 2024, North America leads the market with a valuation of 2.5 USD Billion, expected to reach 4.0 USD Billion in 2035, highlighting its majority holding in the sector due to advanced healthcare infrastructure and significant Research and Development investments. 

    Europe follows with a valuation of 1.8 USD Billion in 2024, projected to grow to 2.8 USD Billion by 2035, driven by strong regulations and a preference for non-invasive procedures.The Asia Pacific region, valued at 1.1 USD Billion in 2024 and growing to 1.8 USD Billion by 2035, is gaining traction thanks to increasing healthcare accessibility and patient awareness. In South America, the market is smaller, holding 0.4 USD Billion in 2024 and reaching 0.6 USD Billion by 2035, but showcases potential growth due to rising investments in healthcare.

    The Middle East and Africa, valued at 0.41 USD Billion in 2024 and 0.8 USD Billion in 2035, represents a developing market with growing demand for diagnostic imaging. Each region's engagement highlights the varying degrees of market development and opportunity within the Nuclear Medicine Market segmentation.

    Nuclear Medicine Market Regional Insights

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The Nuclear Medicine Market is characterized by its dynamic and competitive landscape, which plays a crucial role in the effective diagnosis and treatment of various diseases, particularly in oncology, cardiology, and neurology. As the demand for advanced imaging techniques increases, several key players are vying for a significant share of the market. These companies are continually investing in research and development to innovate and maintain strong product portfolios while also engaging in strategic partnerships and collaborations with healthcare providers and research institutions. 

    Such actions enable these firms to stay ahead in this highly specialized field, providing state-of-the-art solutions that enhance diagnostic accuracy and improve patient outcomes. The competitive environment is marked not only by technological advancements but also by regulatory challenges, reimbursement issues, and the need for extensive clinical validation. This further amplifies the rivalry among companies striving to offer safe, efficient, and effective nuclear medicine products.In the Nuclear Medicine Market, Bracco Imaging has established a solid presence owing to its innovative approaches and comprehensive product offerings.

    The company focuses on the development of advanced radiopharmaceuticals and imaging agents that enhance the diagnostic process. With a robust portfolio that includes key imaging agents, Bracco Imaging effectively addresses the needs of healthcare professionals by providing high-quality products that equip them for accurate diagnostics in nuclear medicine. 

    The company's strengths lie in its commitment to research and development, which has enabled it to consistently launch new and improved products that meet regulatory requirements and address clinical expectations. Furthermore, Bracco Imaging's collaborations with healthcare institutions and strong distribution networks globally enhance its market reach and have a significant impact on its growth trajectory in the nuclear medicine sector.Bayer AG is a formidable player in the Nuclear Medicine Market, renowned for its innovative product offerings and solid market position.

    The company has developed a range of radiopharmaceuticals and imaging agents that cater specifically to the realm of oncology and other serious medical conditions. Bayer AG’s strengths include its extensive research capabilities, which have led to the launch of several key products that are well-received in the market. 

    The company places significant emphasis on strategic mergers and acquisitions to bolster its product pipeline and expand its market presence. These strategic initiatives not only broaden its product offerings but also enhance its competitive edge in the global arena. Bayer AG is committed to advancing the field of nuclear medicine through ongoing investment in research and engaging in collaborations that explore novel therapies and diagnostic techniques, ensuring its position as a leader in the nuclear medicine landscape.

    Key Companies in the Nuclear Medicine Market market include

    Industry Developments

    The Nuclear Medicine Market has seen notable developments recently, particularly with advancements in technology and increasing applications in clinical settings. Major players such as GE Healthcare and Siemens Healthineers are focusing on enhancing imaging techniques, which is vital for precise diagnostics. 

    In terms of recent mergers and acquisitions, Bracco Imaging announced the acquisition of a leading radiopharmaceutical company in August 2023, augmenting their product portfolio significantly. Additionally, Bayer AG completed the purchase of a niche radiopharmaceutical business in July 2023, further consolidating their presence in the market.

    The impact of these activities is reflected in the market valuation, which is projected to grow due to technological advancements and increasing demand for targeted cancer therapies. Companies like Lantheus Medical Imaging are also expanding their offerings, which is expected to contribute to market growth in the upcoming years. 

    Other noteworthy developments in the last couple of years include the increased adoption of PET scans and the rise of personalized medicine, with advancements around March 2022 showcasing these trends gaining momentum globally. The Nuclear Medicine Market is poised for ongoing evolution as stakeholders invest in Research and Development to meet rising healthcare demands.

    Future Outlook

    Nuclear Medicine Market Future Outlook

    <p>The Global Nuclear Medicine Market is projected to grow at a 11.35% CAGR from 2025 to 2035, driven by technological advancements, increasing cancer prevalence, and enhanced diagnostic capabilities.</p>

    New opportunities lie in:

    • <p>Develop targeted radiopharmaceuticals for personalized medicine applications. Invest in advanced imaging technologies to improve diagnostic accuracy. Expand global distribution networks to enhance market reach and accessibility.</p>

    <p>By 2035, the Nuclear Medicine Market is expected to exhibit robust growth, reflecting advancements and increased adoption across healthcare sectors.</p>

    Market Segmentation

    Nuclear Medicine Market End User Outlook

    • Hospitals
    • Diagnostic Imaging Centers
    • Academic Research Institutions
    • Pharmaceutical Companies

    Nuclear Medicine Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Nuclear Medicine Market Procedure Outlook

    • Positron Emission Tomography
    • Single-Photon Emission Computed Tomography
    • Radiotherapy
    • Brachytherapy

    Nuclear Medicine Market Application Outlook

    • Diagnostic Imaging
    • Therapeutic Applications
    • Radiopharmaceutical Production
    • Research Applications

    Nuclear Medicine Market Radioisotope Type Outlook

    • Technetium-99m
    • Iodine-131
    • Fluorine-18
    • Yttrium-90

    Report Scope

    Report Attribute/MetricDetails
    Market Size 202410.63(USD Billion)
    Market Size 203534.69 (USD Billion)
    Compound Annual Growth Rate (CAGR)11.35% (2025 - 2035)
    Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledBracco Imaging, Bayer AG, Radiopharma, Nordion, GE Healthcare, Siemens Healthineers, Lantheus Medical Imaging, IHF Healthcare, Phillips Healthcare, NorthStar Medical Radioisotopes, Cardinal Health, Advanced Accelerator Applications, Elekta AB, Toshiba Medical Systems
    Segments CoveredApplication, Radioisotope Type, End User, Procedure, Regional
    Key Market OpportunitiesIncreased demand for targeted therapies, Advancements in imaging technologies, Rising prevalence of chronic diseases, Growing investment in research and development, Expanding applications in personalized medicine
    Key Market DynamicsInnovative radiopharmaceuticals development, Increasing cancer prevalence, Growing aging population, Advancements in imaging technology, Supportive government initiatives
    Countries CoveredNorth America, Europe, APAC, South America, MEA
    Market Size 202511.84 (USD Billion)

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    What is the projected growth of the Nuclear Medicine market?

    The Nuclear Medicine market is the expected increase in total market value of 34.69 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Nuclear Medicine market?

    Nuclear Medicine market size was valued at approximately 10.63 billion USD in 2024. This figure will reach 34.69 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Nuclear Medicine market?

    Nuclear Medicine market is expected to grow at a CAGR of 11.35% between 2025 and 2035.

    How much will the Nuclear Medicine market be worth by 2035?

    Nuclear Medicine market is expected to be worth of 34.69 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Nuclear Medicine market perform over the next 10 years?

    Over the next 10 years the Nuclear Medicine market is expected to shift from usd billion 10.63 to 34.69 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    Which region is expected to dominate the Nuclear Medicine Market by 2035?

    North America is expected to dominate the market with a valuation of 4.0 USD Billion by 2035.

    What are the market values for Diagnostic Imaging and Therapeutic Applications in 2024?

    In 2024, the market value for Diagnostic Imaging is 2.84 USD Billion and for Therapeutic Applications is 1.8 USD Billion.

    Who are the major players in the Nuclear Medicine Market?

    Major players include Bracco Imaging, Bayer AG, GE Healthcare, and Cardinal Health, among others.

    How does the Nuclear Medicine Market size differ between 2024 and 2035?

    The market is expected to grow from 6.21 USD Billion in 2024 to 10.0 USD Billion in 2035.

    What is the market value of Research Applications in the Nuclear Medicine Market by 2035?

    The market value for Research Applications is projected to be 0.8 USD Billion by 2035.

    1. Table of Contents
    2. EXECUTIVE SUMMARY
    3. Market Overview
    4. Key Findings
    5. Market Segmentation
    6. Competitive Landscape
    7. Challenges and Opportunities
    8. Future Outlook
    9. MARKET INTRODUCTION
    10. Definition
    11. Scope of the study
    12. Research Objective
    13. Assumption
    14. Limitations
    15. RESEARCH METHODOLOGY
    16. Overview
    17. Data Mining
    18. Secondary Research
    19. Primary Research
    20. Primary Interviews and Information Gathering Process
    21. Breakdown of Primary Respondents
    22. Forecasting Model
    23. Market Size Estimation
    24. Bottom-Up Approach
    25. Top-Down Approach
    26. Data Triangulation
    27. Validation
    28. MARKET DYNAMICS
    29. Overview
    30. Drivers
    31. Restraints
    32. Opportunities
    33. MARKET FACTOR ANALYSIS
    34. Value chain Analysis
    35. Porter's Five Forces Analysis
    36. Bargaining Power of Suppliers
    37. Bargaining Power of Buyers
    38. Threat of New Entrants
    39. Threat of Substitutes
    40. Intensity of Rivalry
    41. COVID-19 Impact Analysis
    42. Market Impact Analysis
    43. Regional Impact
    44. Opportunity and Threat Analysis
    45. Nuclear Medicine Market, BY Application (USD Billion)
    46. Diagnostic Imaging
    47. Therapeutic Applications
    48. Radiopharmaceutical Production
    49. Research Applications
    50. Nuclear Medicine Market, BY Radioisotope Type (USD Billion)
    51. Technetium-99m
    52. Iodine-131
    53. Fluorine-18
    54. Yttrium-90
    55. Nuclear Medicine Market, BY End User (USD Billion)
    56. Hospitals
    57. Diagnostic Imaging Centers
    58. Academic Research Institutions
    59. Pharmaceutical Companies
    60. Nuclear Medicine Market, BY Procedure (USD Billion)
    61. Positron Emission Tomography
    62. Single-Photon Emission Computed Tomography
    63. Radiotherapy
    64. Brachytherapy
    65. Nuclear Medicine Market, BY Regional (USD Billion)
    66. North America
    67. US
    68. Canada
    69. Europe
    70. Germany
    71. UK
    72. France
    73. Russia
    74. Italy
    75. Spain
    76. Rest of Europe
    77. APAC
    78. China
    79. India
    80. Japan
    81. South Korea
    82. Malaysia
    83. Thailand
    84. Indonesia
    85. Rest of APAC
    86. South America
    87. Brazil
    88. Mexico
    89. Argentina
    90. Rest of South America
    91. MEA
    92. GCC Countries
    93. South Africa
    94. Rest of MEA
    95. Competitive Landscape
    96. Overview
    97. Competitive Analysis
    98. Market share Analysis
    99. Major Growth Strategy in the Nuclear Medicine Market
    100. Competitive Benchmarking
    101. Leading Players in Terms of Number of Developments in the Nuclear Medicine Market
    102. Key developments and growth strategies
    103. New Product Launch/Service Deployment
    104. Merger & Acquisitions
    105. Joint Ventures
    106. Major Players Financial Matrix
    107. Sales and Operating Income
    108. Major Players R&D Expenditure. 2023
    109. Company Profiles
    110. MediRadiant
    111. Financial Overview
    112. Products Offered
    113. Key Developments
    114. SWOT Analysis
    115. Key Strategies
    116. Bracco Imaging
    117. Financial Overview
    118. Products Offered
    119. Key Developments
    120. SWOT Analysis
    121. Key Strategies
    122. Nordion
    123. Financial Overview
    124. Products Offered
    125. Key Developments
    126. SWOT Analysis
    127. Key Strategies
    128. TheraBiologics
    129. Financial Overview
    130. Products Offered
    131. Key Developments
    132. SWOT Analysis
    133. Key Strategies
    134. United Imaging Healthcare
    135. Financial Overview
    136. Products Offered
    137. Key Developments
    138. SWOT Analysis
    139. Key Strategies
    140. Philips
    141. Financial Overview
    142. Products Offered
    143. Key Developments
    144. SWOT Analysis
    145. Key Strategies
    146. Canon Medical Systems
    147. Financial Overview
    148. Products Offered
    149. Key Developments
    150. SWOT Analysis
    151. Key Strategies
    152. SelenoMed
    153. Financial Overview
    154. Products Offered
    155. Key Developments
    156. SWOT Analysis
    157. Key Strategies
    158. Radiopharm Theranostics
    159. Financial Overview
    160. Products Offered
    161. Key Developments
    162. SWOT Analysis
    163. Key Strategies
    164. AquaBounty Technologies
    165. Financial Overview
    166. Products Offered
    167. Key Developments
    168. SWOT Analysis
    169. Key Strategies
    170. Lantheus Medical Imaging
    171. Financial Overview
    172. Products Offered
    173. Key Developments
    174. SWOT Analysis
    175. Key Strategies
    176. Bayer
    177. Financial Overview
    178. Products Offered
    179. Key Developments
    180. SWOT Analysis
    181. Key Strategies
    182. Elekta
    183. Financial Overview
    184. Products Offered
    185. Key Developments
    186. SWOT Analysis
    187. Key Strategies
    188. Siemens
    189. Financial Overview
    190. Products Offered
    191. Key Developments
    192. SWOT Analysis
    193. Key Strategies
    194. General Electric
    195. Financial Overview
    196. Products Offered
    197. Key Developments
    198. SWOT Analysis
    199. Key Strategies
    200. Appendix
    201. References
    202. Related Reports

    Nuclear Medicine Market Segmentation

    Nuclear Medicine Market By Application (USD Billion, 2019-2035)

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    Nuclear Medicine Market By Radioisotope Type (USD Billion, 2019-2035)

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    Nuclear Medicine Market By End User (USD Billion, 2019-2035)

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    Nuclear Medicine Market By Procedure (USD Billion, 2019-2035)

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    Nuclear Medicine Market By Regional (USD Billion, 2019-2035)

    North America

    Europe

    South America

    Asia Pacific

    Middle East and Africa

    Nuclear Medicine Market Regional Outlook (USD Billion, 2019-2035)

    North America Outlook (USD Billion, 2019-2035)

    North America Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    North America Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    North America Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    North America Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    North America Nuclear Medicine Market by Regional Type

    US

    Canada

    US Outlook (USD Billion, 2019-2035)

    US Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    US Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    US Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    US Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    CANADA Outlook (USD Billion, 2019-2035)

    CANADA Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    CANADA Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    CANADA Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    CANADA Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    Europe Outlook (USD Billion, 2019-2035)

    Europe Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    Europe Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    Europe Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    Europe Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    Europe Nuclear Medicine Market by Regional Type

    Germany

    UK

    France

    Russia

    Italy

    Spain

    Rest of Europe

    GERMANY Outlook (USD Billion, 2019-2035)

    GERMANY Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    GERMANY Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    GERMANY Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    GERMANY Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    UK Outlook (USD Billion, 2019-2035)

    UK Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    UK Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    UK Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    UK Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    FRANCE Outlook (USD Billion, 2019-2035)

    FRANCE Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    FRANCE Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    FRANCE Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    FRANCE Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    RUSSIA Outlook (USD Billion, 2019-2035)

    RUSSIA Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    RUSSIA Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    RUSSIA Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    RUSSIA Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    ITALY Outlook (USD Billion, 2019-2035)

    ITALY Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    ITALY Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    ITALY Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    ITALY Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    SPAIN Outlook (USD Billion, 2019-2035)

    SPAIN Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    SPAIN Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    SPAIN Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    SPAIN Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    REST OF EUROPE Outlook (USD Billion, 2019-2035)

    REST OF EUROPE Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    REST OF EUROPE Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    REST OF EUROPE Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    REST OF EUROPE Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    APAC Outlook (USD Billion, 2019-2035)

    APAC Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    APAC Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    APAC Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    APAC Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    APAC Nuclear Medicine Market by Regional Type

    China

    India

    Japan

    South Korea

    Malaysia

    Thailand

    Indonesia

    Rest of APAC

    CHINA Outlook (USD Billion, 2019-2035)

    CHINA Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    CHINA Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    CHINA Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    CHINA Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    INDIA Outlook (USD Billion, 2019-2035)

    INDIA Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    INDIA Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    INDIA Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    INDIA Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    JAPAN Outlook (USD Billion, 2019-2035)

    JAPAN Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    JAPAN Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    JAPAN Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    JAPAN Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    SOUTH KOREA Outlook (USD Billion, 2019-2035)

    SOUTH KOREA Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    SOUTH KOREA Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    SOUTH KOREA Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    SOUTH KOREA Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    MALAYSIA Outlook (USD Billion, 2019-2035)

    MALAYSIA Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    MALAYSIA Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    MALAYSIA Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    MALAYSIA Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    THAILAND Outlook (USD Billion, 2019-2035)

    THAILAND Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    THAILAND Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    THAILAND Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    THAILAND Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    INDONESIA Outlook (USD Billion, 2019-2035)

    INDONESIA Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    INDONESIA Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    INDONESIA Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    INDONESIA Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    REST OF APAC Outlook (USD Billion, 2019-2035)

    REST OF APAC Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    REST OF APAC Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    REST OF APAC Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    REST OF APAC Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    South America Outlook (USD Billion, 2019-2035)

    South America Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    South America Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    South America Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    South America Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    South America Nuclear Medicine Market by Regional Type

    Brazil

    Mexico

    Argentina

    Rest of South America

    BRAZIL Outlook (USD Billion, 2019-2035)

    BRAZIL Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    BRAZIL Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    BRAZIL Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    BRAZIL Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    MEXICO Outlook (USD Billion, 2019-2035)

    MEXICO Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    MEXICO Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    MEXICO Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    MEXICO Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    ARGENTINA Outlook (USD Billion, 2019-2035)

    ARGENTINA Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    ARGENTINA Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    ARGENTINA Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    ARGENTINA Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)

    REST OF SOUTH AMERICA Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    REST OF SOUTH AMERICA Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    REST OF SOUTH AMERICA Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    REST OF SOUTH AMERICA Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    MEA Outlook (USD Billion, 2019-2035)

    MEA Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    MEA Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    MEA Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    MEA Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    MEA Nuclear Medicine Market by Regional Type

    GCC Countries

    South Africa

    Rest of MEA

    GCC COUNTRIES Outlook (USD Billion, 2019-2035)

    GCC COUNTRIES Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    GCC COUNTRIES Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    GCC COUNTRIES Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    GCC COUNTRIES Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    SOUTH AFRICA Outlook (USD Billion, 2019-2035)

    SOUTH AFRICA Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    SOUTH AFRICA Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    SOUTH AFRICA Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    SOUTH AFRICA Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

    REST OF MEA Outlook (USD Billion, 2019-2035)

    REST OF MEA Nuclear Medicine Market by Application Type

    Diagnostic Imaging

    Therapeutic Applications

    Radiopharmaceutical Production

    Research Applications

    REST OF MEA Nuclear Medicine Market by Radioisotope Type

    Technetium-99m

    Iodine-131

    Fluorine-18

    Yttrium-90

    REST OF MEA Nuclear Medicine Market by End User Type

    Hospitals

    Diagnostic Imaging Centers

    Academic Research Institutions

    Pharmaceutical Companies

    REST OF MEA Nuclear Medicine Market by Procedure Type

    Positron Emission Tomography

    Single-Photon Emission Computed Tomography

    Radiotherapy

    Brachytherapy

     

     

    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027